The Science of
Certainty
Gubra enables you to progress your preclinical pharmacology development for metabolic disorders with more certainty than any other research partner
NASH
Benefit from our extensive NASH know-how and test your compound in our validated DIO mouse model of NASH.
Obesity
Tap into our vast scientific experience with diet-induced obesity (DIO) models and other commercially available models.
Diabetic complications
Check out our novel rodent models of diabetic nephropathy and diabetic cardiomyopathy.
Diabetes
Qualify and advance your assessment of novel compounds to treat type 2 diabetes and diabetic complications.
Imaging
Gubra now offers state-of-the art 3D imaging technologies to visualize pathogenesis and compound distribution in whole organs with single cell resolution.
See the visualization and read more
Press Release
Find out more about the partner program between Boeringer Ingelheim Pharma and Gubra.